Otsuka America Pharmaceutical names new president and CEO
Mr Altmeyer succeeds interim president and CEO of Otsuka America Pharmaceutical, Dean Haubrich, who has been leading the company since August 1, 2008 and has been named chairman
Amberstone Biosciences has signed a partnership and licence agreement with Shanghai Henlius Biotech for conditionally activated T-cell engager candidates to treat solid tumours.